ADC Therapeutics ADCT
NYSE ADCT
$1.47 -0.05 (-3.29%)
As of: Oct 21, 2026 · 10:53 AM EDT

ADC Therapeutics (ADCT) EBIT (2020 - 2026)

Updated

ADC Therapeutics (ADCT) recorded EBIT of -$25.41 million in Q2 2026, compared with -$44.15 million a year earlier.

Analysis

ADC Therapeutics (ADCT) EBIT (2020 - 2026) Analysis & Trends

On a TTM basis, ADC Therapeutics' EBIT came in at -$125.78 million as of Jun 30, 2026.

  • Quarterly EBIT has ranged from -$69.41 million in Q2 2022 to -$3.11 million in Q3 2022 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Eli Lilly 1,132.04 Bn 1,100.62 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 614.86 Bn 533.39 Bn 17.26 Bn 7.14 Bn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 6.43 Bn
4 Merck 367.14 Bn 321.52 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.69 Bn 235.37 Bn 12.86 Bn 3.16 Bn
7 Amgen 236.43 Bn 191.82 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 190.71 Bn 164.90 Bn 6.22 Bn -10.39 Bn
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 4.27 Bn
10 ADC Therapeutics 227.87 Mn -718.32 Mn 16.90 Mn -25.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.41 Mn
Mar 31, 2026 -25.25 Mn
Sep 30, 2025 -30.97 Mn
Jun 30, 2025 -44.15 Mn
Mar 31, 2025 -28.46 Mn
Sep 30, 2024 -35.56 Mn
Jun 30, 2024 -29.04 Mn
Mar 31, 2024 -33.61 Mn
Sep 30, 2023 -36.15 Mn
Jun 30, 2023 -39.65 Mn
Mar 31, 2023 -51.57 Mn
Sep 30, 2022 -3.11 Mn
Jun 30, 2022 -69.41 Mn
Mar 31, 2022 -40.36 Mn
Sep 30, 2021 -57.79 Mn
Jun 30, 2021 -70.48 Mn
Mar 31, 2021 -70.67 Mn
Sep 30, 2020 -52.43 Mn
Jun 30, 2020 -44.95 Mn
Mar 31, 2020 -43.89 Mn
API Access

ADC Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ADCT&period=max&api_key=YOUR_API_KEY